Centers For Disease Control And Prevention

This early-stage study is testing a new rotavirus vaccine that is given through a dissolving microneedle patch on the skin, instead of a shot. The trial will enroll 50 healthy adults aged 18 to 45 to see if the vaccine is safe and whether it triggers an immune response. Participa…

This study tests whether two new 17-week drug combinations can treat pulmonary tuberculosis as effectively as the standard 6-month regimen. About 288 people with TB will receive one of three daily pill regimens. The goal is to see if shorter treatment can clear the infection fast…

This study was designed to test a program that helps caregivers of people with traumatic brain injury improve their problem-solving skills. It planned to enroll adults aged 19 and older, but was withdrawn before any participants joined, so no results are available.